Abstract: Provided is a lithium secondary battery having a higher capacity and a longer life. The lithium secondary battery includes: a positive electrode including a material capable of intercalation and deintercalation of a lithium ion; a lithium ion-conductive electrolyte including a salen-based metal complex; and a negative electrode including a material capable of occlusion and release of a lithium metal or a lithium ion. The salen-based metal complex is selected from (R,R)-(?)-N,N?-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminotitanium chloride (TiSl), VSl, CrSl, MnSl, FeSl, CoSl, and RuSl.

Abstract: A periphery monitoring device includes, for example, an acquirer and a controller. The acquirer acquires a vehicle image of the vehicle and a peripheral image representing peripheral situation of a vehicle based on image data output from an imager mounted on the vehicle to image the surroundings of the vehicle, and to be displayed in an overhead mode. The vehicle image is to be displayed on the peripheral image in the overhead mode. The controller causes a virtual vehicle image to be displayed on the peripheral image together with the vehicle image. The virtual vehicle image represents, in the overhead mode, a state of the vehicle when traveling at a current steering angle.

Abstract: A low-molecular-weight polysulfated hyaluronic acid derivative useful for treatment of an allergic disease. An agent for treatment of an allergic disease selected from pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma, represented by the following general formula (IA) or (IB); wherein n represents a number of 0 to 15; R's each independently represent a hydrogen atom or an SO3H group etc.

Abstract: Thiazole compounds for inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and the production of interleukin 4. The compounds of the invention are represented by general formula (1): wherein A is any one of the following groups (i)-(iii): (i) —CH(OH)—B— wherein B is a C1-6 alkylene group; (ii) —COCH(COOR3)-Bb- wherein R3 is a C1-6 alkyl group and Bb is a C1-6 alkylene group; and (iii) -Bc- wherein Bc is a C2-6 alkylene group, and include optical isomers and salts of the compounds.

Abstract: A low-molecular-weight polysulfated hyaluronic acid derivative useful for prevention and/or treatment of an allergic disease. An agent for prevention and/or treatment of an allergic disease selected from pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma, represented by the following general formula (IA) or (IB); wherein n represents a number of 0 to 15; R?s each independently represent a hydrogen atom or an SO3H group etc.

Abstract: A blood testing device includes (i) a main body, having a puncture component for puncturing a finger, a finger contact component where the finger to be punctured is placed during puncture by the puncture component, a sensor receptacle in which a blood sensor can be mounted, and a measurement component that measures concentration of a component in the blood held in the blood sensor, and (ii) at least one main body support that has a first space into which a finger other than the finger to be punctured is inserted, and that is provided to the main body directly or via another member.

Abstract: Thiazole compounds for inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and the production of interleukin 4. The compounds of the invention are represented by general formula (1): wherein A is any one of the following groups (i)-(iii): (i) —CH(OH)-B- wherein B is a C1-6 alkylene group; (ii) —COCH(COOR3)-Bb- wherein R3 is a C1-6 alkyl group and Bb is a C1-6 alkylene group; and (iii) -Bc- wherein Bc is a C2-6 alkylene group, and include optical isomers and salts of the compounds.

Abstract: Thiazole compounds for inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and the production of interleukin 4. The compounds of the invention are represented by general formula (1): wherein A is any one of the following groups (i) and (ii): (i) —CO—B— wherein B is a C1-6 alkylene group and (ii) —CO—Ba— wherein Ba is a C2-6 alkenylene group, and include optical isomers and salts of the compounds.

Abstract: An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4.